BioSpace News Archive

Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases, today announced the first patient has been dosed in their Phase III, global clinical trial (RSJ10333) of SHR0302,

LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the appointment of Daniel K. Spiegelman as an independent board advisor.

Up to 200,000 Johnson & Johnson Ebola vaccine regimens will be made available as part of a WHO early access clinical program now underway in Sierra Leone

Prilenia’s global phase 3 trial in Huntington’s Disease (PROOF-HD) has enrolled 120 patients on schedule reaching 25% of its target PROOF-HD is the most advanced clinical trial in HD assessing impact on clinical progression

Spacelabs Healthcare®, a division of OSI Systems, Inc., and Masimo announced that they have extended their partnership in patient monitoring to integrate SET® pulse oximetry, NomoLine® capnography, rainbow SET® Pulse CO-Oximetry, SedLine® brain function monitoring, and O3® regional oximetry into select Spacelabs multi-parameter monitors.

Systems Oncology, a biotechnology company, today announced that Dr. Spyro Mousses, CEO and Co-Founder of Systems Oncology, will participate in a fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Thursday, May 20 th at 12:40pm EST.

KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics ® discovery platform to systematically screen the whole genome to identify optimal gene targets for oncology and autoimmune disease, today announced the appointment of Chris Heberlig, MBA, as Chief Financial Officer.

Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2021, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 13, 2021.

IsoPlexis, the leader in single-cell proteomics, announced that Jason Ou has joined the company as General Manager for the Asia-Pacific region.

Havn Life Sciences Inc., a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, is pleased to announce it has entered into a supply agreement with ATMA Journey Centers Inc.